Supported by

Mitral valve replacement and repair

Find all the latest content on mitral valve replacement and repair published on this website.

Building on the years of experience with TAVI, mitral valve replacement and repair is now beginning to take-off with a vast array of new techniques and options. Certain devices, for instance in mitral repair, are now widely used. To understand this complex field a knowledge and mastery is required covering the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Mitral valve replacement and repair

722 results

PCRonline @ ESC Congress 2025: the interventional cardiology perspective!

26 Jul 2025

Stay updated with the latest in interventional cardiology at #ESCCongress 2025!

PCRonline @ ESC Congress 2025

The PCR Textbook

08 Jul 2025

The PCR Textbook covers the length and breadth of percutaneous cardiovascular interventional practice, in particular diagnostic and therapeutic areas.

The PCR Textbook in percutaneous cardiovascular interventional practice

Atrial flow regulator implantation through atrial septal defect of previous mitral transcatheter edge-to-edge repair: bailout strategy

30 Jun 2025

Mitral transcatheter edge-to-edge repair (M-TEER) has reshaped the prognosis for heart failure patients with secondary mitral regurgitation, but recurrence remains a real challenge when surgical options are off the table.

This case highlights an innovative use of an atrial flow regulator (AFR) to manage elevated left atrial...

Interatrial shunt after mitral transcatheter edge-to-edge repair

Mitral session from PCR London Valves 2025: Abbott

26 Nov 2025

Watch these recordings from PCR London Valves 2025 and EuroPCR 2025 on Mitral.

Mitral session from PCR London Valves 2025: Abbott

Repair and replace: latest insights in transcatheter treatment of mitral and tricuspid regurgitation

20 May 2025 – From EuroPCR 2025

Join Michael Mullen, Federico De Marco, and Philipp Lurz as they discuss the latest breakthroughs in the treatment of mitral and tricuspid regurgitation at EuroPCR 2025. In this roundtable session, they delve into both repair and replacement techniques, offering insights into new systems and their impact...

Repair and replace: latest insights in transcatheter treatment of mitral and tricuspid regurgitation

Structural and Valvular Interventions: EuroPCR 2025 highlights

22 May 2025 – From EuroPCR 2025

Christopher Cook, Nicolas Dumonteil, and Bernard Prendergast share their top EuroPCR 2025 highlights in structural heart interventions. Challenging cases like re-do TAVI, coronary re-access difficulties, and leaflet modification took center stage in case-based and LIVE sessions. Cutting-edge research was featured too, including a meta-analysis combining the...

Structural: EuroPCR 2025 highlights

Paravalvular leak closure in TMVR

23 May 2025 – From EuroPCR 2025

This session addresses paravalvular leak closure in transcatheter mitral valve replacement, exploring multiple plug techniques, complex leak management, and combined antegrade and retrograde approaches, providing nuanced insights into challenging mitral prosthesis complications.

Paravalvular leak closure in TMVR

TMVIV - TMVIR and its challenges

23 May 2025 – From EuroPCR 2025

Explore the challenges and innovations in transcatheter mitral valve-in-valve and valve-in-ring procedures. This session presents alternative access routes, management of paraannular compromise, and complex cases involving ECMO support and unexpected outcomes, offering valuable insights into advanced mitral interventions.

TMVIV - TMVIR and its challenges

Combined LAA closure and transcatheter mitral valve repair - LIVE Case

22 May 2025 – From EuroPCR 2025

An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...

Combined LAA closure and transcatheter mitral valve repair - LIVE Case

When mitral disease is not the only problem on mitral TEER patients

22 May 2025 – From EuroPCR 2025

Explore the multifaceted challenges in patients undergoing mitral TEER when additional mitral and tricuspid pathologies coexist. This session reviews data from the EXPANDed studies on tricuspid regurgitation post-mitral TEER, one-year outcomes based on cardiac damage extent, pulmonary hypertension dynamics, and the long-term mortality causes in this...

When mitral disease is not the only problem on mitral TEER patients